PTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016

Unfavorable public investment markets could put emerging bio/pharma growth and CDMO spending at risk in 2017

Bribery and corruption may be the latest challenge to supply chain integrity.

Recent research of efficient chiral synthesis technologies reveals potential uses in API manufacturing.

NIST’s monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.

CDMO Saneca Pharma has sold registration dossiers for more than 20 pharmaceutical products to Xantis Pharma and will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma.

The agency recommends suspending drugs developed with bioequivalence studies performed at Semler Research Centre Private Ltd, Bangalore, India.

The company will expand its service offerings to include oligonucleotide API development and manufacture.

The Nexera-i MT from Shimadzu incorporates two flow lines, which allow for both UHPLC and HPLC analysis.

The pen injectors will be produced at Catalent’s Brussels, Belgium facility.

Zenith appointed Carlos Machado as serialization director to lead the company’s sales, operations, and post project support services.

The company opened a new service center in San Juan, Puerto Rico.

The company will invest €18 million in its Kaysersberg facility to expand blow-fill-seal capacity.

GenPak Solutions is cited by FDA for cGMP violations at its Hilliard, Ohio facility.

The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.

The company invested $50 million in an expansion at its Charles City, Iowa facility.

The company invested in the MicroSeq Rapid Microbial Identification System from Applied Biosystems at its Illinois facility.

EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.

UPS will expand its clinical trial logistics capabilities to include drug and vaccine development.